Nutanix has garnered an average recommendation of “Moderate Buy” from nineteen analysts covering the company, with eleven issuing buy ratings and eight assigning hold ratings. The collective twelve-month price objective stands at 71.07, reflecting a balanced yet optimistic view on the company’s medium-term outlook among the research community.

Several major brokerages have recently adjusted their price objectives on Nutanix. Royal Bank of Canada lowered its target from 74.00 to 65.00 while maintaining an outperform rating. Bank of America trimmed its objective from 93.00 to 75.00 alongside a buy rating, and Goldman Sachs reduced its forecast from 95.00 to 75.00 with a buy recommendation. KeyCorp also cut its target from 95.00 to 65.00, affirming an overweight stance, and Wall Street Zen moved its rating one notch to hold.

In its latest quarter, Nutanix reported revenue of 670.6 million, narrowly missing consensus forecasts of 677.2 million, while delivering earnings per share of 0.41 in line with estimates. Year-over-year revenue growth reached 13.5%, and net margin stood at 8.43%. The company recorded a negative return on equity of 32.95%, and analysts now project full-year EPS of 0.31 based on current guidance.

Institutional investors continue to hold a dominant 85.3% stake in Nutanix. Notable movements include a 67.3% increase by Dynamic Technology Lab Private Ltd during the second quarter, adding 11,670 shares, and a new position established by Norges Bank valued at approximately 264 million. Swiss National Bank expanded its holdings by 6.7%, while Prudential Financial and Schroder Investment Management Group increased their stakes by 1,069.5% and 19.1%, respectively, signaling renewed confidence from large asset managers.